Class IITerminated in FDA datasetAug 1, 2016

Split Cooked King Crab Leg & Claw, repacked by Odyssey, net wt. 20 lbs. per box, keep frozen.

Recalling firm: Odyssey Enterprises Inc

Why it was recalled

Cooked King crab legs & claws were recalled due to a contamination with Listeria monocytogenes.

Check your package

Compare the exact product and package details with the label you have.

ProductSplit Cooked King Crab Leg & Claw, repacked by Odyssey, net wt. 20 lbs. per box, keep frozen. UPC 28575 96323 The label is read in parts: "***SPLIT COOKED KING CRAB LEG & CLAW***PRODUCT OF RUSSIA***PACKED IN U.S.A. ***NET WT. 20 LBS***KEEP FROZEN***PACKED FOR: ODYSSEY BY: NORTHWEST SEAFOOD PROCESSORS INC***206 SW Michigan ST Seattle, WA 98106***FURTHER PREPARATION BEFORE SERVING AS FOLLOWS: FROM FROZEN STATE BOIL, STEAM OR BROIL FOR 8-10 MINUTES OR BAKE IN 400F OVEN FOR 8-10 MINUTES***".

FDA code information

Lot 63043

Match the product, package size, and code together. A missing match does not guarantee safety.

Full FDA record and distribution details

Original product description

Split Cooked King Crab Leg & Claw, repacked by Odyssey, net wt. 20 lbs. per box, keep frozen. UPC 28575 96323 The label is read in parts: "***SPLIT COOKED KING CRAB LEG & CLAW***PRODUCT OF RUSSIA***PACKED IN U.S.A. ***NET WT. 20 LBS***KEEP FROZEN***PACKED FOR: ODYSSEY BY: NORTHWEST SEAFOOD PROCESSORS INC***206 SW Michigan ST Seattle, WA 98106***FURTHER PREPARATION BEFORE SERVING AS FOLLOWS: FROM FROZEN STATE BOIL, STEAM OR BROIL FOR 8-10 MINUTES OR BAKE IN 400F OVEN FOR 8-10 MINUTES***".

Recall details

Recall number
F-2037-2016
Event ID
74848
FDA status
Terminated
Initiated
Aug 1, 2016
Reported
Sep 14, 2016
Classified
Sep 8, 2016
Terminated
Sep 8, 2016
Quantity
400 cases (20 lbs. per case)
Location
Seattle, WA, United States
Initiation type
Voluntary: Firm initiated
Notification
Letter

Where it was distributed

distributed in WI

FDA source record · F-2037-2016

Data updated September 16, 2026. View official FDA data ↗

Follow official FDA and manufacturer guidance.